Anna C. Beck MD
Breast Cancer, Hematologic Oncology, Hospice & Palliative
Huntsman Cancer Institute, University of Utah
Join to view full profile
1950 Circle of HopeClinic 2BSalt Lake City, UT 84112
Phone+1 801-585-0100
Fax+1 801-585-2984
Dr. Beck is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 1993
U Utah Affil Hospitals1993- University of Utah HealthFellowship, Hematology and Medical Oncology, 1989 - 1992
- University of Utah HealthResidency, Internal Medicine, 1986 - 1989
- University of Utah HealthInternship, Internal Medicine, 1986 - 1987
Certifications & Licensure
UT State Medical License 1987 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Integrative and Holistic MedicineHolistic and Integrative Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer Start of enrollment: 2012 May 16
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- 5 citationsTOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer.Christos Vaklavas, Cindy B Matsen, Zhengtao Chu, Kenneth M Boucher, Sandra D Scherer
JCO Precision Oncology. 2024-07-01 - 2 citationsRisk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic.Elena S Aßmann, Jennifer Ose, Cassandra A Hathaway, Laura B Oswald, Sheetal Hardikar
Journal of Behavioral Medicine. 2024-06-01 - 1 citationsPatient and Caregiver Perceptions of an Interface Design to Communicate Artificial Intelligence-Based Prognosis for Patients With Advanced Solid Tumors.Elizabeth A Sloss, Jordan P McPherson, Anna C Beck, Jia-Wen Guo, Carolyn H Scheese
JCO Clinical Cancer Informatics. 2024-04-01
Press Mentions
Clinical Study of Psychedelic Drugs for Cancer Patients Could Be a ‘Game Changer’February 1st, 2022
Access to Clinical Trial Buoys Utah Cancer PatientNovember 26th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
